301 related articles for article (PubMed ID: 9665817)
1. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
Madlener M; Parks WC; Werner S
Exp Cell Res; 1998 Jul; 242(1):201-10. PubMed ID: 9665817
[TBL] [Abstract][Full Text] [Related]
2. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
Salmela MT; Karjalainen-Lindsberg ML; Jeskanen L; Saarialho-Kere U
Mod Pathol; 2003 Feb; 16(2):108-14. PubMed ID: 12591962
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice.
Fässler R; Sasaki T; Timpl R; Chu ML; Werner S
Exp Cell Res; 1996 Jan; 222(1):111-6. PubMed ID: 8549652
[TBL] [Abstract][Full Text] [Related]
5. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
7. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
[TBL] [Abstract][Full Text] [Related]
8. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.
Di Girolamo N; McCluskey P; Lloyd A; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):671-9. PubMed ID: 10711680
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2194-200. PubMed ID: 9761302
[TBL] [Abstract][Full Text] [Related]
10. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA.
Ashcroft GS; Herrick SE; Tarnuzzer RW; Horan MA; Schultz GS; Ferguson MW
J Pathol; 1997 Oct; 183(2):169-76. PubMed ID: 9390029
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
12. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.
Majka S; McGuire P; Colombo S; Das A
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):210-5. PubMed ID: 11133870
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 and -2 expression is differentially regulated in cultured keratinocytes and within the regenerating epidermis of cutaneous wounds.
Gassmann MG; Werner S
Exp Cell Res; 2000 Jul; 258(1):23-32. PubMed ID: 10912784
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice.
Manuel JA; Gawronska-Kozak B
Matrix Biol; 2006 Oct; 25(8):505-14. PubMed ID: 17010584
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.
Vaalamo M; Karjalainen-Lindsberg ML; Puolakkainen P; Kere J; Saarialho-Kere U
Am J Pathol; 1998 Apr; 152(4):1005-14. PubMed ID: 9546361
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
Ries C; Popp T; Egea V; Kehe K; Jochum M
Toxicology; 2009 Sep; 263(1):26-31. PubMed ID: 18809459
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
19. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing.
Kane CJ; Hebda PA; Mansbridge JN; Hanawalt PC
J Cell Physiol; 1991 Jul; 148(1):157-73. PubMed ID: 1907288
[TBL] [Abstract][Full Text] [Related]
20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
